DOI . ORG {}

Analyzed Page
Matching Content Categories
CMS
Monthly Traffic Estimate
How Does Doi.org Make Money
Keywords
Topics
Questions
Schema
Social Networks
External Links
Analytics And Tracking
Libraries
Hosting Providers
CDN Services

We began analyzing https://www.tandfonline.com/doi/full/10.2217/imt.12.52, but it redirected us to https://www.tandfonline.com/doi/full/10.2217/imt.12.52. The analysis below is for the second page.

Title[redir]:
Immunotherapy for TB: Immunotherapy: Vol 4 , No 6 - Get Access
Description:
Mycobacterium tuberculosis, the causative agent of TB, is one of the world‘s most devastating human pathogens. In 2010, there were an estimated 8.8 million incident cases of TB and approximately 1....

Matching Content Categories {📚}

Education
Non-Profit & Charity
Science

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🏙️ Massive Traffic: 50M - 100M visitors per month

Based on our best estimate, this website will receive around 80,904,851 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We see no obvious way the site makes money.

Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Doi.org might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {🔍}

access, journals, sciences, open, taylor, francis, search, article, online, journal, studies, browse, log, find, environment, science, health, immunotherapy, articles, group, page, publish, social, cart, issue, pdf, author, technology, information, medicine, register, read, financial, content, close, menu, select, calls, papers, suggester, publishing, guidance, services, subject, earth, engineering, humanities, physical, add, crossref,

Topics {✒️}

social care medicine downloaded article pdf twitter page taylor article /doi/full/10 francis group journal search calls subject matter cart search downloaded article pdfs limited period read lists articles find guidance journals books institution access published online issue 6 immunotherapy receive personalised research crossref citations journals browse citing articles based effectively control tb evolved complex strategies design immunotherapeutic strategies applicable share back author services home open mark dohertymedical affairs tb search information ancient human pathogen journals a date register article https financial involvement financial interest financial conflict register log crossref icon tb remains issues volume 4 major reason review discusses taylor publish specific diseases read article human pathogens human host find

Questions {❓}

Forgot password?
Why publish with us?

Schema {🗺️}

BreadcrumbList:
      context:https://schema.org
      itemListElement:
            type:ListItem
            position:1
            name:Home
            item:https://www.tandfonline.com/
            type:ListItem
            position:2
            name:All Journals
            item:https://www.tandfonline.com/action/showPublications?pubType=journal
            type:ListItem
            position:3
            name:Medicine
            item:https://www.tandfonline.com/subjects/medicine-dentistry-nursing-and-allied-health
            type:ListItem
            position:4
            name:Immunotherapy
            item:https://www.tandfonline.com/iimy20
            type:ListItem
            position:5
            name:List of Issues
            item:https://www.tandfonline.com/loi/iimy20
            type:ListItem
            position:6
            name:Volume 4, Issue 6
            item:https://www.tandfonline.com/toc/iimy20/4/6
            type:ListItem
            position:7
            name:Immunotherapy for TB
ListItem:
      position:1
      name:Home
      item:https://www.tandfonline.com/
      position:2
      name:All Journals
      item:https://www.tandfonline.com/action/showPublications?pubType=journal
      position:3
      name:Medicine
      item:https://www.tandfonline.com/subjects/medicine-dentistry-nursing-and-allied-health
      position:4
      name:Immunotherapy
      item:https://www.tandfonline.com/iimy20
      position:5
      name:List of Issues
      item:https://www.tandfonline.com/loi/iimy20
      position:6
      name:Volume 4, Issue 6
      item:https://www.tandfonline.com/toc/iimy20/4/6
      position:7
      name:Immunotherapy for TB
PublicationIssue:
      id:#issue
      issueNumber:6
      datePublished:2012-06-01
      isPartOf:
         id:#periodical
         type:
            PublicationVolume
            Periodical
         name:Immunotherapy
         issn:
            1750-743X
            1750-7448
         volumeNumber:4
         publisher:Taylor & Francis Group
["PublicationVolume","Periodical"]:
      id:#periodical
      name:Immunotherapy
      issn:
         1750-743X
         1750-7448
      volumeNumber:4
      publisher:Taylor & Francis Group
ScholarlyArticle:
      mainEntityOfPage:https://www.tandfonline.com/doi/full/10.2217/imt.12.52
      url:https://www.tandfonline.com/doi/full/10.2217/imt.12.52
      isPartOf:#periodical
      sameAs:https://doi.org/10.2217/imt.12.52
      identifier:10.2217/imt.12.52
      isAccessibleForFree:false
      articleSection:Review
      name:Immunotherapy for TB
      headline:Immunotherapy for TB
      abstract:Mycobacterium tuberculosis was one of the first human pathogens to be identified as the cause of a specific disease – TB. TB was also one of the first specific diseases for which immunotherapy was attempted. In more than a century since, multiple different immunotherapies have been attempted, alongside vaccination and antibiotic treatment, with varying degrees of success. Despite this, TB remains a major worldwide health problem that causes nearly 2 million deaths annually and has infected an estimated 2 billion people. A major reason for this is that M. tuberculosis is an ancient human pathogen that has evolved complex strategies for persistence in the human host. It has thus been long understood that, to effectively control TB, we will need to address the ability of the pathogen to establish a persistent, latent infection in most infected individuals. This review discusses what is presently known about the interaction of M. tuberculosis with the immune system, and how this knowledge has been used to design immunotherapeutic strategies.
      description:Mycobacterium tuberculosis was one of the first human pathogens to be identified as the cause of a specific disease – TB. TB was also one of the first specific diseases for which immunotherapy was attempted. In more than a century since, multiple different immunotherapies have been attempted, alongside vaccination and antibiotic treatment, with varying degrees of success. Despite this, TB remains a major worldwide health problem that causes nearly 2 million deaths annually and has infected an estimated 2 billion people. A major reason for this is that M. tuberculosis is an ancient human pathogen that has evolved complex strategies for persistence in the human host. It has thus been long understood that, to effectively control TB, we will need to address the ability of the pathogen to establish a persistent, latent infection in most infected individuals. This review discusses what is presently known about the interaction of M. tuberculosis with the immune system, and how this knowledge has been used to design immunotherapeutic strategies.
      author:
            type:Person
            name:T Mark Doherty
      keywords:bacterial, immunotherapy, latency, TB
      pageStart:629
      pageEnd:647
      datePublished:2012-07-13
      publisher:
         type:Organization
         name:Taylor & Francis
         logo:
            type:ImageObject
            url:https://www.tandfonline.com/pb-assets/Images/Taylor_and_Francis_Group_Logo-1742461082.png
Person:
      name:T Mark Doherty
Organization:
      name:Taylor & Francis
      logo:
         type:ImageObject
         url:https://www.tandfonline.com/pb-assets/Images/Taylor_and_Francis_Group_Logo-1742461082.png
ImageObject:
      url:https://www.tandfonline.com/pb-assets/Images/Taylor_and_Francis_Group_Logo-1742461082.png

Social Networks {👍}(4)

External Links {🔗}(108)

Analytics and Tracking {📊}

Google Analytics
Google Analytics 4
Google Tag Manager
Google Universal Analytics
Hotjar

Libraries {📚}

Dropzone.js
jQuery

Emails and Hosting {✉️}

Mail Servers:

mx.zoho.eu
mx2.zoho.eu
mx3.zoho.eu

Name Servers:

josh.ns.cloudflare.com
zita.ns.cloudflare.com

CDN Services {📦}

Cookielaw
Optimizely
Pbgrd

2.69s.